Steroid‑Induced Avascular Necrosis: Stage‑by‑Stage Progression

Initial Steroid Exposure and Early Microvascular Effects

Corticosteroids such as prednisone or dexamethasone are potent anti‑inflammatory agents, but when used at high doses or for prolonged periods they alter lipid metabolism within bone marrow. The excess fat can form emboli that block small medullary vessels, while steroids also increase clotting tendency and reduce fibrinolysis. These combined effects diminish blood flow to the femoral head or other susceptible bones.

Endothelial cells lining the marrow sinusoids become injured, releasing less nitric oxide and more endothelin‑1, which raises vascular tone and intraosseous pressure. Simultaneously, steroid‑induced suppression of osteoblast activity reduces new bone formation, while osteoclast activity may remain relatively unchanged. The net result is a hypoxic environment that weakens the trabecular framework before any obvious structural change appears.

At this early stage patients usually feel no pain, and standard radiographs appear normal. Sensitive magnetic resonance imaging, particularly fat‑suppressed T2‑weighted sequences, can reveal patches of low signal on T1 and high signal on T2 that correspond to marrow edema and early necrosis. Detecting these changes offers a window for interventions that might slow progression.

Bone Marrow Edema and the Onset of Symptoms

When the ischemic insult persists, the marrow space fills with fluid and inflammatory cells, producing bone marrow edema that is clearly visible on MRI. On T1‑weighted images the edema appears as decreased signal, whereas on T2‑weighted or STIR sequences it shows increased signal. This pattern is often the earliest reliable sign of avascular necrosis before the bone loses its shape.

Patients may start to notice a dull ache in the groin or thigh that worsens with weight‑bearing activity and eases with rest. The discomfort is often intermittent at first, but can become more constant as the necrotic area expands. Night pain is also reported, possibly due to increased intraosseous pressure when lying down.

Although the necrotic core is forming, the overlying cartilage and subchondral bone still maintain continuity, so the joint surface remains smooth on plain X‑ray. Clinicians rely on the patient’s history of steroid use, symptom pattern, and MRI findings to suspect early avascular necrosis and to advise activity modification or further investigation.

Subchondral Collapse and Early Radiographic Signs

As necrosis advances, the weakened subchondral bone can no longer support the overlying cartilage, leading to a characteristic crescent sign on conventional radiographs. This sign appears as a subchondral lucent line with a denser sclerotic margin, indicating that a fragment of bone has begun to separate from the healthy core.

The loss of structural integrity causes the femoral head to flatten or become irregular, losing its normal spherical contour. This change alters the mechanics of the hip joint, increasing stress on the remaining cartilage and accelerating wear. Patients often report a deeper, more persistent pain that is less relieved by rest.

Pain may now be present during both activity and rest, and the range of motion, especially internal rotation and abduction, becomes limited. A limp frequently develops as the body tries to off‑load the affected side. At this point, plain X‑ray is usually sufficient to confirm the diagnosis and to assess the degree of collapse.

Advanced Joint Damage and Functional Decline

When the subchondral collapse progresses, the articular cartilage over the necrotic bone begins to deteriorate, exposing the underlying bone to joint fluid. This exposure triggers secondary osteoarthritic changes, including cartilage loss, subchondral sclerosis, and the formation of cysts within the femoral head.

Pain intensifies, often becoming severe enough to disturb sleep and to require analgesic medication. Functional limitation is marked; patients may need a cane or walker to ambulate, and activities such as climbing stairs or rising from a chair become difficult. The joint may also demonstrate crepitus on movement.

Imaging at this stage shows joint space narrowing, osteophyte formation at the periphery, and a flattened or mushroom‑shaped femoral head. The combination of necrotic bone and arthritic changes often leads clinicians to recommend joint‑preserving procedures only if a substantial amount of healthy bone remains; otherwise, total hip arthroplasty becomes the definitive treatment.

Long‑Term Outlook and Clinical Considerations

The timeline from steroid exposure to symptomatic collapse varies widely. Factors that accelerate progression include higher cumulative steroid dose, longer duration of therapy, underlying autoimmune or hematologic disease, and genetic predispositions affecting lipid metabolism. Some patients develop symptoms within months, while others remain asymptomatic for years.

Early detection offers the best chance to modify the disease course. Strategies may involve tapering or discontinuing the offending steroid when clinically safe, using bisphosphonates or statins to reduce lipid emboli, and employing joint‑protecting measures such as limited weight bearing or core decompression. These interventions aim to preserve the remaining viable bone and delay collapse.

When the joint has already collapsed, the focus shifts to restoring function and relieving pain. Rehabilitation after surgical intervention emphasizes muscle strengthening, gait training, and gradual return to activities. Long‑term follow‑up monitors for prosthesis wear, loosening, or late‑stage complications, ensuring that the patient’s quality of life is maintained.